• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
FRE

FIREBRICK PHARMA LIMITED - News & Media

0.00% ! 6.5¢
Market Cap $16.27M  !
Healthcare Biotechnology
Add to My Watchlist

Firebrick Pharma (ASX:FRE) is an Australian pharmaceutical developer focused on... Firebrick Pharma (ASX:FRE) is an Australian pharmaceutical developer focused on developing and commercializing novel formulations and uses of povidone-iodine. After more than 10 years of R&D including multiple human clinical trials, Firebrick's first product, Nasodine® Nasal Spray, is now available for sale in USA and Singapore.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Articles & Videos

Study spruiks Firebrick's Nasodine spray as 'effective treatment for common cold'

A long-run study looking into leading Firebrick Pharma (ASX:FRE) product Nasodine has suggested the nasal spray can be an effective treatment for the common cold following a dive into the company’s Phase III trials.Listen to the HotCopper podcast for in-depth discussions and insig...

10 Jun 2025 10:07 (AEST)

'Expansion' the watchword in Firebrick's sales-heavy quarter

Firebrick Pharma Ltd has recorded a busy March quarter for 2025, marked by its move into retailing Nasodine in Singapore

16 Apr 2025 14:38 (AEST)

Invest in the Future of Healthcare – Firebrick Pharma’s Investor Webinar

"We have a moral, ethical obligation to make Nasodine available worldwide," - Firebrick Pharma founder & CEO, Dr Peter Molloy.

27 Feb 2025 15:46 (AEDT)

The world needs Nasodine: Here's why...

With the ongoing parade of pandemic threats, a tappable market for Firebrick Pharma's Nasodine isn’t going anywhere anytime soon.

21 Jan 2025 06:00 (AEDT)

History tells us there’ll be another pandemic. Given that, has Firebrick Pharma been wildly overlooked?

We live in a world that’s only just stopped reeling from the international COVID-19 viral pandemic.The same world where microbes and viruses are becoming ever-resistant to antibiotics and other treatments (and where mystery outbreaks and bird flu have come to the fore).And where @...

12 Dec 2024 08:51 (AEDT)

Firebrick Pharma launching retail Nasodine sales in Singapore

Firebrick Pharma (ASX:FRE) has inked a deal with Guardian, a pharmacy chain in Singapore, to launch retail sales of its Nasodine product.

25 Nov 2024 11:07 (AEDT)

Firebrick's Nasodine is now on sale in Singapore

Firebrick Pharma (ASX:FRE) has announced that its Nasodine® nasal spray product is now available in Singapore.

13 Jun 2024 09:04 (AEST)

Firebrick Pharma sees substantial holder up stake to 12% in placement

Betadine-like nasal spray provider Firebrick – whose flagship product has recently gone live for sale in the US – has raised $0.8M.

17 May 2024 10:27 (AEST)

Firebrick Pharma's US launch of Nasal Spray is nothing to be sneezed at

Australian pharmaceutical developer, Firebrick Pharma (ASX:FRE) has launched its latest product, Nasodine Nasal Spray, in the US market.

17 Apr 2024 14:40 (AEST)



Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
6.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $16.27M
Open High Low Value Volume
6.8¢ 6.8¢ 6.5¢ $1.129K 17K

Buyers (Bids)

No. Vol. Price($)
1 24891 6.5¢
 

Sellers (Offers)

Price($) Vol. No.
6.8¢ 79497 2
View Market Depth
Last trade - 12.22pm 19/09/2025 (20 minute delay) ?
FRE (ASX) Chart

Top Stories

'Set and forget' vs. DIY super: Which strategy wins?

We’ve all been told the same story: Work hard, keep tipping money into your super, and let @time in the market” do the heavy lifting. Supposedly, that’s the ticket to a comfortable retirement. But here’s the uncomfortable truth...
HotCopper Highlights: Stakk's out-of-nowhere Robinhood deal; ADNOC dumps Santos after first date & more Greetings and welcome to HotCopper Highlights, I’m Jon Davidson, in this end of week wrap we look at the stocks you were watching and discussing the most this week, and let’s kick off looking at the most viewed. Banking software player Stakk attracted a lot of eyes...
Market shows partial interest in Noviqtech as company flags launch of 'quantum' chatbot NoviqTech shares were +16% higher late arvo as the company declared the successful launch of its "Quantum Intelligence" business.
Kula Gold bursts out gates +60% after hitting visible gold in first Mt Palmer drill hole Smallcap miner Kula Gold has burst out the gates on Friday after reporting "visible gold" in its first diamond drill hole at Mt Palmer.
Sayona, Mesoblast, Mader: All the biggest ASX director trades from the last week The biggest Director Trades this week came from Sayona Mining non-executive director Allan Buckler, who transferred $216 million in shares.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.